Bank of America
FTH

Bank of America’s Faeth Therapeutics FTH Stock Holding History

Bank of America’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Buy
33,025
+32,719
+10,692% +$654K ﹤0.01% 4506
2025
Q4 		$3.27K Sell
306
-325
-52% -$3.14K ﹤0.01% 6337
2025
Q3 		$5.96K Buy
631
+48
+8% +$398 ﹤0.01% 7284
2025
Q2 		$5K Buy
583
+576
+8,229% +$4.13K ﹤0.01% 7295
2025
Q1 		$56 Hold
7
– – ﹤0.01% 7956
2024
Q4 		$67 Sell
7
-6
-46% -$60 ﹤0.01% 7816
2024
Q3 		$154 Buy
13
+6
+86% +$73 ﹤0.01% 7626
2024
Q2 		$86 Sell
7
-4,531
-100% -$94.3K ﹤0.01% 7736
2024
Q1 		$95.3K Sell
4,538
-1
-0% -$17 ﹤0.01% 6262
2023
Q4 		$62.8K Hold
4,539
– – ﹤0.01% 6540
2023
Q3 		$72.6K Hold
4,539
– – ﹤0.01% 6377
2023
Q2 		$103K Buy
4,539
+40
+0.9% +$1.17K ﹤0.01% 6187
2023
Q1 		$135K Buy
4,499
+2,065
+85% +$61.2K ﹤0.01% 6126
2022
Q4 		$72.5K Buy
2,434
+589
+32% +$17.3K ﹤0.01% 6357
2022
Q3 		$57K Buy
1,845
+1,001
+119% +$39.3K ﹤0.01% 6616
2022
Q2 		$38K Sell
844
-1,556
-65% -$58.3K ﹤0.01% 6962
2022
Q1 		$110K Buy
2,400
+1,148
+92% +$91.4K ﹤0.01% 6811
2021
Q4 		$146K Buy
1,252
+826
+194% +$123K ﹤0.01% 6676
2021
Q3 		$90K Sell
426
-158
-27% -$28.8K ﹤0.01% 6778
2021
Q2 		$115K Sell
584
-114
-16% -$28.2K ﹤0.01% 6441
2021
Q1 		$202K Buy
+698
New +$234K ﹤0.01% 6033

Other funds holding FTH

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Bank of America's FTH Position: Q1 2026 in Review

Bank of America increased its Faeth Therapeutics (FTH) stake by 10,692% in Q1 2026, buying an estimated $654K and bringing the position to 33,025 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #4506.

Bank of America first reported a position in FTH in Q1 2021 and has held it in 21 quarters since. 30 funds tracked by Wall St. Rank hold FTH as of Q1 2026.

  • Bank of America held 33,025 shares of Faeth Therapeutics worth $1.04M as of Q1 2026.
  • Bank of America bought 32,719 Faeth Therapeutics shares in Q1 2026, an estimated $654K.
  • Faeth Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4506 holding.
  • Bank of America first reported a position in Faeth Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • 30 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.